MedTech S.A.
USPTO PatentsView assignee record - 29 granted patents across 19 technology areas, recorded in grant years 2017–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).
The verdict
According to USPTO PatentsView, Medtech ranks #10,680 of 49,997 tracked US assignees by granted-patent volume, with 29 patents across 19 technology areas.
- #10,680
- of 49,997 US assignees by volume
- Top 12%
- by Innovation Score (51.1/100)
- 19.0
- avg claims per patent
- +475%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R10680 · Foreign Corporation #10,680 · 29 grants
GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL
- GRANTS-SMALL 29 grants
- UPPER-Q #10,680/49,997
- PHOTO-FINISH MeMed Diagnostics
- CPC-FOCUS A61B · 19 areas
- INNOV-PAR 51.1/100
- CLAIMS-RICH 19.0 claims/avg
- TYPE-FRNCORP Foreign Corp
- VEL-SURGE +475% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: MeMed Diagnostics Ltd. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Medtech’s 51.1 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Medtech
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Arena Pharmaceuticals · near
Arena Pharmaceuticals · near
51 score
- Clarkson University · near
Clarkson University · near
51 score
- MedTech · this assignee
MedTech · this assignee
51 score
- Schneider Toshiba… · near
Schneider Toshiba… · near
51 score
- Shenzhen Royole · near
Shenzhen Royole · near
51 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Medtech's Innovation Score is 51.1/100 (top 12% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Medtech?
Each dot is one of Medtech’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Medtech’s own 19.0 claims/patent is ABOVE the 13.8 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Medtech's grants concentrate
MedTech S.A. is a focused PatentsView assignee: 19 CPC subclasses with 96.6% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2020 (5 grants) versus a trough of 2 in 2017. By volume, Medtech sits between Molo Design, Ltd. and Moraine Corporation.
Medtech's three-year grant acceleration
MedTech S.A. shows 15 grants in 2022–2024 against only 8 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at MedTech's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Molo Design
Molo Design, Ltd.
29 patents
- MSC Software
MSC.Software Corporation
29 patents
- Muehlbauer & KG
Muehlbauer GMBH & Co. KG
29 patents
- Memed Diagnostics
MeMed Diagnostics Ltd.
29 patents
- Micell
Micell Technologies, Inc.
29 patents
- Mississippi Lime
Mississippi Lime Company
29 patents
- Moderna Therapeut…
Moderna Therapeutics, Inc.
29 patents
- Moraine
Moraine Corporation
29 patents
- Medtech ◀
MedTech S.A.
29 patents
What this shows MedTech holds 29 patents at rank #10,687, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near MedTech
By rank, the assignees closest to #10,687 in granted patent volume.
- Molo Design, Ltd. #10,683 · 29 patents
- MSC.Software Corporation #10,684 · 29 patents
- Muehlbauer GMBH & Co. KG #10,685 · 29 patents
- MeMed Diagnostics Ltd. #10,686 · 29 patents
- Micell Technologies, Inc. #10,688 · 29 patents
- Mississippi Lime Company #10,689 · 29 patents
- Moderna Therapeutics, Inc. #10,690 · 29 patents
- Moraine Corporation #10,691 · 29 patents
Leaders in A61B (Diagnosis)
Other assignees with the most granted patents in MedTech's primary technology class.
- Covidien LP 5,709 in class
- Koniniklijke Philips N.V. 3,414 in class
- Olympus Corporation 2,758 in class
- Boston Scientific Scimed, Inc. 2,362 in class
- Cilag GmbH International 2,063 in class
- Intuitive Surgical Operations, Inc. 1,921 in class
- DePuy Synthes Products, Inc. 1,796 in class
- Ethicon, Inc. 1,762 in class
Assignees with similar portfolio profiles
Two PlainPatent-derived peer sets for MedTech, neither rank-band nor same-CPC leaders (those blocks stay above). In A61B (Diagnosis), MedTech ranks #661 of 7,127 assignees by patent count in that subclass.
Similar innovation score
Nearest assignees by Innovation Score (51 here).
Medtech's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
51 Top 12% higher than 88% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2017 | 2 | 6.9% |
| 2018 | 2 | 6.9% |
| 2020 | 5 | 17.2% |
| 2021 | 3 | 10.3% |
| 2022 | 5 | 17.2% |
| 2023 | 5 | 17.2% |
| 2024 | 5 | 17.2% |
| 2025partial year | 2 | 6.9% |
Which technologies does MedTech S.A. patent most?
Top 15 of 19 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
MedTech S.A.'s patent record in context - here's where to go next.
- MedTech S.A.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 96.6% of its portfolio - see every assignee active in that class. Explore A61B
- Ranked #10,680 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare MedTech S.A. against Molo Design, Ltd., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 51.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.